EURO-EWING 99: European ewing tumour working initiative of national groups

Phase 3

Completed

• Conditions: Ewing's sarcoma; Bone cancer; Cancer

• Registration Number: ISRCTN61438620
• Lead Sponsor: niversity of Birmingham

Brief Summary

2006 Results article in http://www.ncbi.nlm.nih.gov/pubmed/16572419 results 2010 Results article in https://www.ncbi.nlm.nih.gov/pubmed/20547982 results 2015 Results article in https://www.ncbi.nlm.nih.gov/pubmed/26104542 results 2017 Results article in https://www.ncbi.nlm.nih.gov/pubmed/28436593 results

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2002-08-19
• Study Completion: 2017-03-30
• Last Update Posted: 8 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1695

Inclusion Criteria

1. Histologically confirmed Ewing's tumour of the bone or soft tissue
2. Age less than 50
3. Completed pre-treatment investigations allowing prognostic group definition
4. No previous chemotherapy
5. Informed consent
6. Normal cardiac and renal function
7. Interval between date of definitive biopsy and registration less than 45 days
8. Interval between date of definitive biopsy and start of chemotherapy less than 30 days

Exclusion Criteria

Does not comply with above inclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified